McDermott Will & Schulte advises WillowWood in sale of majority stake to CVC Catalyst III | McDermott Skip to main content

McDermott Will & Schulte advises WillowWood in sale of majority stake to CVC Catalyst III

Überblick


Global law firm McDermott Will & Schulte represented WillowWood Holdings Inc., one of the leading manufacturers of prosthetic products, including prosthetic liners, feet, knees, and enabling technologies, across the US and key European markets, in the sale of a majority stake to CVC Catalyst III.

Blue Sea Capital and management will reinvest meaningfully alongside CVC to support WillowWood’s next phase of growth. Closing of the transaction is subject to approval by the relevant regulatory authorities and is expected in the third quarter of 2026. Financial terms of the transaction were not disclosed.

The McDermott team was led by Fred Levenson and Matt Carter with invaluable support from Sean McGuire, Dane Chapman, Greg Heltzer, Kelly Holloway, Nate Wolfe, Galen Spielman, Royce Brosseau, Josh Cohrs, Jae Lee, Alex Ruiz, Darshak Dholakia, Wondha Cadet.

Read the press release here.

Über uns


Leading organizations turn to global law firm McDermott Will & Schulte for a better way to address legal challenges, connect with those at the forefront, and drive stronger outcomes. Working across more than 20 offices globally, our 1,700+ lawyers act on data-driven insights, deep relationships, and unmatched industry experience to deliver on our commitment of Always Better.